Sugi Predict

Sugi Predict / Compounds / SCHEMBL7166993

SCHEMBL7166993

SCHEMBL7166993

Cc1c(Cl)cc(C#N)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 2/20 0.42
▸ TTR P02766 2/20 0.41
▸ ALB P02768 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ VCAM1 P19320 3/20 0.39
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GPR35 Q9HC97 2/20 0.35
▸ KCNJ6 P48051 1/20 0.35
▸ KCNJ5 P48544 1/20 0.35
▸ KCNJ3 P48549 1/20 0.35
▸ GRM5 P41594 2/20 0.34
▸ PDK1 Q15118 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ PDK3 Q15120 1/20 0.33
▸ PDK4 Q16654 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13696502 0.88 AR (0.42) ARTTRALBALDH1A1CYP2A6
SCHEMBL15806352 0.86 AR (0.38) ARTTRALBALDH1A1CYP2A6
SCHEMBL10120483 0.84 KCNJ6 (0.40) ARTTRALBALDH1A1CYP2A6
SCHEMBL31292412 0.84 TTR (0.48) ARTTRALBALDH1A1CYP2A6
SCHEMBL23408412 0.81 CYP2C19 (0.40) ARTTRALBALDH1A1CYP2A6
SCHEMBL14606500 0.81 GPR35 (0.39) ARTTRALBALDH1A1CYP2A6
SCHEMBL7931074 0.78 VCAM1 (0.46) ARTTRALBALDH1A1VCAM1
SCHEMBL15321757 0.77 TTR (0.45) ARTTRALBALDH1A1CYP2A6
SCHEMBL22664414 0.76 TTR (0.48) ARTTRALBVCAM1MEN1
SCHEMBL15850516 0.76 VCAM1 (0.40) ARTTRALBALDH1A1VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118561708-A Benzoyl bacteria method for synthesizing amine 湖北晟康化工有限公司 2024-08-30 — — CN claimed
US-5136110-A Reacting phenol with suitable aromatic halogen compounds; recovering triaryl bisphenols THE DOW CHEMICAL COMPANY (US) 1992-08-04 — — US claimed
CN-118561708-A Benzoyl bacteria method for synthesizing amine 湖北晟康化工有限公司 2024-08-30 — — CN disclosed
EP-3636636-B1 PYRIDONE COMPOUND AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE MITSUI CHEMICALS AGRO INC (JP) 2022-07-06 — — EP disclosed
WO-2021046347-A1 IMMUNOCONJUGATE SYNTHESIS METHOD BOLT BIOTHERAPEUTICS, INC. (US) 2021-03-11 — — WO disclosed
US-9309240-B2 Pyrazolopyridine compounds, compositions and methods of use GENENTECH, INC. (US) 2016-04-12 — — US disclosed
EP-2640722-B1 PYRAZOLOPYRIDINES AND THEIR USE AS TYK2 INHIBITORS HOFFMANN LA ROCHE (CH) 2015-11-04 — — EP disclosed
US-20140171408-A1 AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE GENENTECH, INC. (US) 2014-06-19 — — US disclosed
US-20130252941-A1 PYRAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2013-09-26 — — US disclosed
US-8486950-B2 Janus kinase inhibitor compounds and methods F. HOFFMANN-LA ROCHE AG (CH) 2013-07-16 — — US disclosed
US-20130096104-A1 IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE GENENTECH, INC. (US) 2013-04-18 — — US disclosed
US-20120202788-A1 AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2012-08-09 — — US disclosed
US-20090234117-A1 Pyrazolopyrimidine Derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-09-17 — — US disclosed
US-20090234117-A1 Pyrazolopyrimidine Derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-09-17 — — US disclosed
EP-0897130-B1 Thermographic recording element FUJIFILM CORP (JP) 2009-07-15 — — EP disclosed
EP-1903045-A1 PYRAZOLOPYRIMIDINE DERIVATIVE Mitsubishi Tanabe Pharma Corporation (JP) 2008-03-26 — — EP disclosed
US-20080039639-A1 Chromane and chromene derivatives and uses thereof WYETH (US) 2008-02-14 — — US disclosed
US-6562823-B1 Inhibition of farnesyl-protein transferase has been shown to block the growth of Ras-transformed cells in soft agar MERCK & CO., INC. 2003-05-13 — — US disclosed
EP-0372656-B1 Polymers comprising spirolactam units SHELL INT RESEARCH (NL) 1995-06-07 — — EP disclosed
US-4968769-A THERMOPLASTICS HAVING DIMENSIONAL STABILITY AT ELEVATED TEMPERATURES SHELL OIL COMPANY (US) 1990-11-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096104-A1 IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE TYK2, IRAK1, IRAK4 AR 1654/4885TTR 2345/4885ALB 3239/4885
US-20130252941-A1 PYRAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE P2RX5, P2RX4, P2RY1 AR 1502/4885TTR 2012/4885ALB 3358/4885
US-20090234117-A1 Pyrazolopyrimidine Derivative MC2R, CRHR1, AVPR2 AR 143/4885TTR 2778/4885ALB 2906/4885
US-20080039639-A1 Chromane and chromene derivatives and uses thereof HTR1A, CHRM1, HTR2C AR 210/4885TTR 3248/4885ALB 4371/4885
US-20140171408-A1 AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F12, CHRM1, NPY1R AR 736/4885TTR 134/4885ALB 1085/4885
US-20120202788-A1 AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F12, CHRM1, NPY1R AR 736/4885TTR 134/4885ALB 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.